Recent News
Eisai, Inc. Retains The Chase Group to Build US Medical Affairs Leadership Team
Eisai, Inc.’s partnership with Merck has proven to be successful with the FDA approval of the Keytruda and Lenvima Combination Treatment. With 13 indications for… Continue Reading →
Akcea Retains The Chase Group to Secure Senior HR Leader for the Company’s Executive Team
The Chase Group is excited to reengage partnership with Akcea Therapeutics to recruit the company’s Vice President of Human Resources. The Vice President will lead… Continue Reading →
The Chase Group Drug Safety Expertise Utilized by Ionis Pharmaceuticals
As the leading innovator in RNA-targeted therapeutics, Ionis Pharmaceuticals requires world-class scientists and business leaders whose passion to innovate is matched only by their commitment… Continue Reading →Eisai, Inc. Cuts to the Chase for Their Recruiting Expertise in Global Medical Affairs, Oncology
A boutique firm working exclusively in life sciences, The Chase Group, with 25+ years’ executive search experience, can identify and deliver the highest quality executives… Continue Reading →Through Partnership With The Chase Group, Aeglea BioTherapeutics Continues Building Rare Disease Clinical Development Leadership Team
The Chase Group is honored to continue our partnership with Aeglea BioTherapeutics as we work to build their Rare Disease Clinical Development Leadership team. As… Continue Reading →Aeglea BioTherapeutics (NASDAQ: AGLE) Partners with The Chase Group to Build Clinical Development Team for Rapidly Expanding Genetic Rare Disease Portfolio
As a leader in engineering human enzymes to address significant unmet medical needs in rare genetic diseases and cancer, Aeglea BioTherapeutics is committed to using… Continue Reading →
Ionis Pharmaceuticals Secures Associate Director, Investor Relations
The Chase Group is pleased to announce our latest placement for Ionis Pharmaceuticals. Due to exciting organizational growth, Ionis welcomes a new Associate Director, Investor… Continue Reading →A Successful Placement at Eisai, Inc.
The Chase Group is pleased to announce the successful completion of the Director, Clinical Research, Neuroscience at Eisai Inc. The successful candidate is a Board… Continue Reading →